HLA-DR and -DQ associations with multiple sclerosis in Turkey

Human Immunology

Volumn 55, Issue 1, 1997, Pages 59-65

  Saruhan Direskeneli, Güber ^a   Esin, S ^a,c   Baykan Kurt, B ^a   Ornek I ^a   Vaughan, R ^b   Eraksoy, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b GUY S HOSPITAL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; DISEASE ASSOCIATION; GENE FREQUENCY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADULT; ALLELES; GENE FREQUENCY; GENOTYPE; HAPLOIDY; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; TURKEY;

EID: 0030967709     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00086-4     Document Type: Article

References (37)

1. Ebers GC, Sadovnick AD: The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1, 1994.
2. Compston DAS, Barret AD: Epidemiology and genetics of multiple sclerosis. Curr Opin Neurol Neurosurg 5:175, 1995.
3. Nepom GT, Erlich H: MHC class-II molecules and autoimmunity. Annu Rev Immunol 9:493, 1991.
4. Wekerle H: Immunopathogenesis of multiple sclerosis. Acta Neurol 13:197, 1991.
5. Waksman BH: Autoimmunity in demyelinating diseases. Ann NY Acad Sci 540:13, 1988.
6. Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153, 1992.
7. Paterson PY: Experimental autoimmune (allergic) encephalomyelitis: induction, pathogenesis and suppression. In Miescher PA, Mueller-Eberhard HJ (eds): Textbook of Immunopathology. New York, Grune and Stratton, 1976, p 179.
8. Tiwari JL, Terasaki PI: HLA and Disease Associations. New York, Springer Verlag, 1985.
9. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgard A, Dupont B: Histocompatibility determinants of multiple sclerosis, with special reference to clinical course. Lancet ii:1221, 1973.
10. Kurdi A, Ayesh I, Abdallat A, Maayta U, McDonald WI, Compston DAS, Batchelor JR: Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and Northern Europeans. Lancet i:1123, 1977.
11. Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F, Cossu P, Pirastu M: Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 38:1749, 1988.
12. Naito S, Kuroiwa Y, Itoyama T, Tsubaki T, Horikawa A, Sasazuki T, Noguchi S, Ohtsuki S, Tokumi H, Miyatake T, Takahata N, Kawanami S, McMicheal AJ: HLA and Japanese multiple sclerosis. Tissue Antigens 12:19, 1978.
13. Gorodezky C, Najera R, Rangel BE, Castro LE, Flores J, Velazquez G, Granados J, Sotelo J: Immunogenetic profile of multiple sclerosis in Mexicans. Human Immunol 6: 364, 1986.
14. Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG: HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada. Neurology 43:548, 1993.
15. Spurkland A, Ronningen KS, Vandvik B, Thorsby E, Vartdal F: HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 30:69, 1991.
16. Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E: Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. Hum Immunol 25:103, 1989.
17. Olerup O, Hillert J: HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38:1, 1991.
18. Marrosu MG, Muntoni F, Murru MR, Costa G, Spinicci G, Pischedda MP, Cianchetti C: HLA-DR and -DQ haplotypes in Sardinian multiple sclerosis [Abstract]. J Neuroimmunol 54:179, 1994.
19. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J: Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 86:7113, 1989.
20. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Silberberg DH, Tourrellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227, 1983.
21. Miller SA, Dykes DD, Polesky HF: Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988.
22. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991. Oxford, UK, Oxford University Press, 1992, p 397.
23. Ratanachaiyavong S, Bidwell JL, Bidwell EA, McGregor AM: Linkage disequilibrium between the HLA-DQA2 alleles and the HLA-DR/DQ complex. Hum Immunol 30:136, 1991.
24. Bignon JD, Fernandez-Vina M: Twelfth International Histocompatibility Workshop HLA class II reference protocol. In Charron D, Fauchet R (eds): HLA 1996. Paris, HLA et Medecine France (in press).
25. Woolf B: On estimating the relation between blood group and disease. Am Hum Genet 9:251, 1955.
26. Svejgaard A, Ryder LP: HLA and disease associations: Detecting the strongest association. Tissue Antigens 43: 18, 1994.
27. Haegert DG, Francis GS: Contribution of a single DQβ chain residue to multiple sclerosis in French Canadians. Hum Immunol 34:85, 1992.
28. Zamanin Ghabanbasani M, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H, Cassiman JJ: Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DRβ1 chain in multiple sclerosis. J Neuroimmunol 59:77, 1995.
29. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL: Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 19:11, 1992.
30. Hao Q, Saida T, Kawakami H, Mine H, Maruya E, Inoko H, Saji H: HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQB1*0602. Hum Immunol 35:116, 1992.
31. Kelly MA, Jacobs KH, Penny MA, Mijovic CH, Nightingale S, Barnett AH, Francis DA: An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean origin. Tissue Antigens 45:197, 1995.
32. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMTh, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44:1, 1994.
33. Allen M, Sandberg-Wollheim M, Sjögren K, Erlich HA, Petterson U, Gyllensten: Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 39:41, 1994.
34. Hillert J, Olerup O: Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype. Neurology 43:163, 1993.
35. Wucherpfennig KW, Hafler DA, Strominger JL: Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proc Natl Acad Sci USA 92:8896, 1995.
36. Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G, Schönbeck S, Bannwarth W, Wekerle H, Hohlfeld R: Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 92:2633, 1993.
37. Haegert DG, Marrosu MG: Genetic susceptibility to multiple sclerosis. Ann Neurol 36(Suppl 2):S204, 1994.